StarStarter Rx

StarStarter Rx is currently being investigated as a treatment for social anxiety disorder, generalized anxiety disorder, and a range of other anxiety conditions.

StarStarter Rx is a digital therapeutic intended to provide a neurobehavioral intervention (Computerized Behavioral Therapy for Social Anxiety) in patients 13 to 65 with Social Anxiety Disorder.

StarStarter Rx treats Social Anxiety Disorders by improving a patient’s anxiety symptoms.

StarStarter Rx’s core therapeutic mechanism of action is a game-based approach to a decades-old area of neurocognitive research known as Attention Bias Modification (ABM).

How Do I Play StarStarter Rx?

You’ll play StarStarter Rx 4 times a week for 4 weeks.

Planet X in the Spectrum galaxy is in distress and it needs your help! An electrical storm has caused the planet to spiral out of its solar system and into deep space.

Each week your mission is to enter deep space and relight the constellations to help Planet X navigate out of the darkness.

Swipe your spaceship to earn stars and light up the constellations.

How Does StarStarter Rx Work?

The human brain is uniquely predisposed to unconscious, sub-second processing of facial expression. StarStarter Rx uses facial archetypes and gamification to retrain emotional and attentional patterns that can drive persistent feelings of social anxiety and distress. StarStarter Rx’s proprietary game mechanics have been designed and optimized through a decade of neuroscientific research using EEG, neurostimulation, eye tracking, heart rate monitoring, and MRI.

Warnings and Limitations

Caution: StartStarter Rx is limited by Federal Law to investigational use only. StartStarter Rx is currently being investigated in various clinical trials to assess its safety and efficacy. For more information, please contact Arcade Therapeutics, Inc.

StarStarter Rx is made available without a prescription under the FDA’s current enforcement policy for digital health devices for treating psychiatric disorders (Document Number: 20023). For more information please contact Arcade Therapeutics, Inc.